HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshihiko Yamaguchi Selected Research

Drug Therapy (Chemotherapy)

1/2021Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report.
11/2020Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
11/2018Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.
11/2017Case series of pleomorphic carcinomas of the lung treated with nivolumab.
1/2017Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report.
3/2015[Safe treatment of lung squamous cell carcinoma with nanoparticle albumin-bound Paclitaxel in a patient with a previous hypersensitivity reaction after docetaxel administration].
7/2006Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
8/2005Simultaneous bilateral spontaneous pneumothorax observed during the administration of gefitinib for lung adenocarcinoma with multiple lung metastases.
9/2004Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshihiko Yamaguchi Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 09/2004
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2004
7Adenocarcinoma of Lung
01/2021 - 08/2005
6Lung Neoplasms (Lung Cancer)
01/2021 - 08/2005
4Disease Progression
01/2021 - 11/2017
4Neoplasm Metastasis (Metastasis)
11/2017 - 09/2004
3Carcinoma (Carcinomatosis)
01/2021 - 09/2015
2Pericardial Effusion
12/2018 - 01/2017
2Adenocarcinoma
09/2015 - 09/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2015 - 03/2015
2Tuberculosis (Tuberculoses)
05/2012 - 04/2011
1Asphyxia (Suffocation)
01/2021
1Antisynthetase syndrome
01/2021
1Idiopathic Pulmonary Fibrosis
11/2020
1Pneumonia (Pneumonitis)
05/2018
1Vitiligo
01/2017
1Small Cell Carcinoma
09/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2015
1Hypersensitivity (Allergy)
03/2015
1Communicable Diseases (Infectious Diseases)
05/2012
1Pleural Tuberculosis
05/2012
1Alcoholic Hepatitis
01/2012
1Purpura
04/2011
1Neutropenia
04/2011
1Thrombocytopenia chromosome breakage
04/2011
1Thrombocytopenia (Thrombopenia)
04/2011
1Pneumothorax
08/2005
1Brain Neoplasms (Brain Tumor)
09/2004
1Body Weight (Weight, Body)
02/2003

Drug/Important Bio-Agent (IBA)

5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
5NivolumabIBA
11/2020 - 01/2017
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 09/2004
3SteroidsIBA
01/2021 - 02/2003
3SurvivinIBA
09/2015 - 12/2014
3Gefitinib (Iressa)FDA Link
01/2012 - 09/2004
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 11/2020
2pembrolizumabIBA
11/2020 - 11/2018
2Monoclonal AntibodiesIBA
12/2018 - 01/2017
2PlatinumIBA
11/2018 - 07/2006
2Tyrosine Kinase InhibitorsIBA
01/2012 - 09/2004
1Pemetrexed (MTA)FDA Link
01/2021
1osimertinibIBA
01/2021
1Cytotoxins (Cytolysins)IBA
11/2020
1pirfenidoneIBA
11/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1B7-H1 AntigenIBA
11/2018
1Anaplastic Lymphoma KinaseIBA
11/2018
1Proteins (Proteins, Gene)FDA Link
01/2017
1Albumin-Bound PaclitaxelFDA Link
03/2015
1Docetaxel (Taxotere)FDA Link
03/2015
1Cisplatin (Platino)FDA LinkGeneric
03/2015
1VimentinIBA
09/2014
1Chemokine CXCL12IBA
05/2012
1Biomarkers (Surrogate Marker)IBA
05/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2012
1Rifampin (Rifampicin)FDA LinkGeneric
04/2011
1PyrazinamideFDA LinkGeneric
04/2011
1Isoniazid (Ftivazide)FDA LinkGeneric
04/2011
1Ethambutol (Myambutol)FDA LinkGeneric
04/2011

Therapy/Procedure

9Drug Therapy (Chemotherapy)
01/2021 - 09/2004
4Therapeutics
01/2021 - 05/2018
2Radiotherapy
11/2017 - 09/2004
1Tracheostomy
01/2021
1Withholding Treatment
01/2018
1Neoadjuvant Therapy
07/2006
1Molecular Targeted Therapy
09/2004
1Diet Therapy (Therapy, Diet)
02/2003